US Nanotechnology Health Care Product Demand to Reach $6.5 Billion in 2009

May 25, 2005, 01:00 ET from The Freedonia Group, Inc.

    CLEVELAND, May 25 /PRNewswire/ -- Demand for nanotechnology health care
 products in the US is projected to increase nearly 50 percent per year to
 $6.5 billion in 2009.  Gains will be led by the introduction of new, improved
 cancer and central nervous system therapies based on solubilization
 technologies.  Diagnostic tests based on nanoarrays and quantum dots, and
 imaging agents based on superparamagnetic iron oxide nanoparticles will also
 see strong growth.  In spite of progress in introducing new products, the vast
 potential of nanotechnology in the health care field will not be fully
 realized for at least a decade as stringent regulatory barriers and technical
 complexities delay the commercialization of targeted drug delivery systems,
 tissue regenerators and other breakthrough products.  However, by 2020, demand
 for nanotechnology health care products is projected to exceed $100 billion.
 These and other trends are presented in Nanotechnology in Health Care, a new
 study from The Freedonia Group, Inc., a Cleveland-based market research firm.
     The need for new or improved medicines in several therapeutic areas will
 lead to the increasing use of nanotechnology in pharmaceutical applications.
 Protein- and peptide-based compounds for cancer, diabetes, infectious diseases
 and organ transplant acceptance will account for most growth.  Over the long
 term, pharmaceutical applications for nanotechnology will extend into most
 therapeutic classes and encompass all types of formulations and delivery
     Advances in nanotechnology are also creating a wealth of opportunities for
 the development of new, improved medical diagnostic products and techniques.
 Nanoparticle formulations of superparamagnetic iron oxide, gadolinium,
 perfluorocarbon and specialty polymers will broaden in vivo imaging
 capabilities by enabling the detection of tumors, plaque, genetic defects and
 other disease states at much earlier stages and with lower, safer
 concentrations of contrast agents.  Several medical supplies and devices will
 emerge as key applications for nanotechnology.
     Nanomaterials are already gaining significant demand as active ingredients
 of burn and wound dressings.  In the long term, advances in nanotechnology are
 expected to lead to the introduction of new, improved medical supply and
 device coatings as well as a new, diverse group of medical implants.  The
 greatest short-term impact of nanotechnology in health care will be in
 therapies and diagnostics for cancer and central nervous system disorders.
     Contact:  Corinne Gangloff,, 440-684-9600

SOURCE The Freedonia Group, Inc.